A Systematic Comparison From Specimen Acquisition To Diagnostic Value

Aug 27, 2026

https://www.chamfondbiotech.com/4-types-of-bone-marrow-biopsy-needles/


I. Microanatomical Basis and Examination Principles

1.1 Histological Composition of Bone Marrow

Bone marrow is the largest and most active hematopoietic organ in the human body, accounting for approximately 4%–5% of total body weight, with a total volume of about 2.6–4.0 kg (in a 70-kg adult). From a histological perspective, bone marrow consists of two core components:

Hematopoietic parenchymal cells: These include hematopoietic stem cells (HSCs), progenitor cells of various lineages, and mature blood cells at different stages of differentiation. Under physiological conditions, hematopoietic stem cells undergo asymmetric division to maintain self-renewal while differentiating along the myeloid (erythroid, granulocytic-monocytic, megakaryocytic) and lymphoid (T-cell, B-cell, NK-cell) pathways.

Hematopoietic microenvironment (HME): Composed of reticular cells, vascular endothelial cells, fibroblasts, adipocytes, extracellular matrix (collagen fibers, fibronectin, laminin, etc.), and nerve endings. This microenvironment secretes cytokines (e.g., SCF, TPO, G-CSF, IL-3) and provides physical scaffolding to finely regulate HSC homing, proliferation, and differentiation.

The vascular system within the bone marrow cavity is characterized by sinusoids​ - a network of thin-walled capillaries with widened endothelial gaps. Mature blood cells traverse the sinusoidal endothelium to enter the peripheral circulation. The structural integrity of these sinusoids directly affects whether aspirated specimens become diluted during bone marrow puncture, and also serves as an important morphological indicator for evaluating neovascularization and abnormal infiltration in biopsy specimens.

1.2 Dynamic Conversion Between Red Marrow and Yellow Marrow

Marrow Type

Composition

Distribution

Functional Status

Red marrow

Hematopoietic cells ~40%–60%, adipocytes ~30%–50%

Distributed throughout all bones in infancy; in adults, concentrated in the skull, sternum, ribs, vertebrae, pelvis, and proximal ends of femurs/humeri

Active hematopoiesis; continuously produces all types of mature blood cells

Yellow marrow

Adipocytes predominate (>70%); very few hematopoietic cells

Shafts of long bones in adults (e.g., distal femoral shaft)

Quiescent state, but can undergo reverse conversion to red marrow ("yellow-to-red reversal") under pathological conditions such as severe anemia, marrow infiltration, or marrow necrosis

Clinical correlation: On bone marrow biopsy sections, HE staining allows direct visual distinction between red marrow areas (cell-dense, darkly stained) and yellow marrow areas (fat vacuoles, lightly stained). Changes in this ratio (e.g., marrow cellularity grading) are key indicators for assessing hematopoietic reserve. Bone marrow aspiration smears cannot provide this spatial information.

1.3 Biological Rationale Behind the Two Examination Methods

The reason bone marrow aspiration and biopsy differ in diagnostic value lies in the fundamentally different dimensions of marrow they "see":

Bone marrow aspiration​ yields a dissociated suspension of free cells​ - the advantage is high-resolution morphological observation and cytochemical staining of individual cells; the disadvantage is the loss of the original spatial relationship of cells within the tissue (the "who's next to whom" information is lost).

Bone marrow biopsy​ yields a three-dimensional tissue section​ - it preserves the spatial relationship between cells and the microenvironment (the "neighborhood effect"), but at the cost of some loss of fine cellular detail due to fixation and sectioning.

The relationship between the two is analogous to "looking at a pile of loose LEGO bricks"​ (aspiration) versus "looking at a fully assembled LEGO model"​ (biopsy) - the former allows clear inspection of each brick's shape and color; the latter reveals the overall structure and assembly pattern. In clinical diagnosis, neither is dispensable.


II. Structural Differences in Operating Instruments

2.1 Design Principles of Bone Marrow Aspiration Needles

The most commonly used aspiration needles in clinical practice are the Jamshidi-modified​ or Roche-type​ needles. Their core components include:

Component

Function

Needle cannula (outer needle)

A hollow metal tube with a beveled or pyramidal tip for penetrating the cortical bone; outer diameter typically 14–16 G (~1.6–2.1 mm)

Stylet (inner core)

A solid metal rod matching the inner diameter of the cannula; when inserted, it seals the needle tip bevel to prevent bone debris or tissue from clogging the lumen during insertion

Depth stop (fixator)

A sliding ring that can be locked along the cannula to preset insertion depth, preventing penetration through the opposite cortical plate (especially critical in sternal puncture)

Needle hub and connector

The terminal connection at the cannula tail for attaching a syringe during aspiration

Working principle: After the needle penetrates the cortex and enters the medullary cavity, the stylet is removed and a dry syringe is attached to generate negative pressure, drawing marrow fluid into the syringe. The magnitude and duration of negative pressure directly affect specimen quality - excessive negative pressure or prolonged aspiration causes massive influx of sinusoidal blood, creating a "dilution artifact."

2.2 Design Principles of Bone Marrow Biopsy Needles

Bone marrow biopsy needles are divided into two major categories with distinctly different design philosophies:

(1) Trephine / Cutting Needles

Represented by the Jamshidi biopsy needle​ (currently the international standard):

Component

Function

Outer cannula (trocar)

A metal tube with a sharp cutting edge at the tip; outer diameter typically 11–13 G (~2.4–3.0 mm)

Inner stylet

A solid rod with a tip slightly longer than the outer cannula; inserted first to penetrate the marrow and prevent tissue clogging

Handle

T-shaped or bow-shaped for two-handed rotational force application

Depth markings

Graduated scale on the cannula surface for visual depth reading

Working principle: The inner stylet and outer cannula are rotated together into the marrow to a predetermined depth. The stylet is then withdrawn, and the outer cannula is rotated further to cut a short cylindrical core of bone marrow tissue, which is then withdrawn together with the cannula.

(2) Rotary Saw Needles (Biopsy punch)

Represented by the Islam biopsy needle, which uses a high-speed rotary cutting mechanism. These needles are less commonly used in clinical practice today and are occasionally employed for specific sites (e.g., sternal biopsy).

2.3 Biological and Clinical Significance of Needle Diameter Differences

Comparison

Aspiration Needle (14–16 G)

Biopsy Needle (11–13 G)

Inner diameter

~1.2–1.6 mm

~2.0–2.8 mm

Tissue trauma

Minimal; puncture site requires virtually no suturing

Slightly greater, but iliac crest biopsy also requires no suturing

Pain level

Mild (comparable to an intensified intramuscular injection)

Somewhat more noticeable, but tolerable with adequate local anesthesia

Specimen volume

0.2–0.5 ml liquid

1.5–2.0 cm long tissue core

Impact on subsequent procedures

Almost none

Same puncture site should not be re-biopsied in the short term (allow ≥4–6 weeks between procedures)

Technical note: The thicker design of the biopsy needle is not simply about "taking more material" - its core purpose is to ensure the tissue core diameter is large enough to preserve sufficient cell numbers and spatial architecture after sectioning. If the core is too thin (<1.5 mm diameter), it is highly prone to fragmentation or distortion during decalcification and sectioning, severely compromising diagnostic value.


III. Fundamental Differences in Specimen Acquisition and Processing

3.1 Bone Marrow Aspiration: Full Workflow of Liquid Specimen Cytological Analysis

(1) Technical Key Points of Aspiration

Syringe selection: A dry 10 ml syringe​ is recommended. Dryness is critical - even trace amounts of moisture can activate the coagulation cascade, causing the marrow sample to clot before smearing, resulting in a catastrophic "no cells to see" situation.

Aspiration volume control: 0.2–0.5 ml is optimal. Too little (<0.1 ml) may result in insufficient cell density on the smear; too much (>1.0 ml) causes excessive sinusoidal blood influx and peripheral blood dilution - the smear will show abundant mature lymphocytes and neutrophils, while the blast percentage is "diluted" downward, easily leading to false negatives or underestimation of disease burden.

Aspiration speed: Should be slow and steady​ to avoid excessive instantaneous negative pressure.

(2) Standardized Smear Preparation Workflow

Step

Operational Details

Quality Control Points

Drop application

Immediately reinsert stylet after aspiration; quickly place a drop of marrow fluid on a pre-labeled slide ~1 cm from one end

From aspiration to smear completion should be within 30–60 seconds​ to prevent cell autolysis or clotting

Spreading

Assistant uses another slide as a spreader at a 30°–45° angle, lightly touching the drop and pushing forward at a steady speed

Spreader speed determines smear thickness: faster = thinner; slower = thicker

Number of slides

Routinely prepare 5–8 smears; prepare an additional 3–5 if cytochemical stains (POX, PAS, NSE, etc.) are planned

Insufficient slides are among the most common clinical problems

Drying

Air-dry naturally; never heat-dry​ (causes cell shrinkage and distortion)

Send for processing immediately after drying

(3) Staining Systems

Routine staining: Wright-Giemsa composite stain clearly displays nuclear chromatin patterns, nucleoli, cytoplasmic granules, and vacuoles.

Cytochemical staining: Includes peroxidase (POX), Sudan black B (SBB), non-specific esterase (NSE), specific esterase (CE), periodic acid-Schiff (PAS), and acid phosphatase (ACP) - critical for FAB classification of acute leukemias.

Iron staining: Prussian blue staining of marrow smears to assess intracellular and extracellular iron - the gold standard for diagnosing iron deficiency anemia and anemia of chronic disease.

3.2 Bone Marrow Biopsy: Full Workflow of Solid Specimen Histopathological Analysis

(1) Technical Key Points of Tissue Acquisition

Preferred site: Posterior superior iliac spine​ - thin cortex, abundant marrow, safe operation, and optimal core length and quality.

Insertion angle: Perpendicular to the bone surface, advanced with rotational motion.

Acquisition depth: Typically advance to 1.5–2.0 cm; deeper penetration increases pain without significantly increasing diagnostic information.

Core retrieval: After rotational cutting, withdraw the outer cannula with the core slowly. A small grayish-white strip of tissue (approximately sesame- to rice-grain-sized) will be visible at the needle tip.

(2) Critical Steps in Specimen Fixation

Step

Operational Details

Why It Matters

Immediate fixation

Place the core immediately​ into 10% neutral buffered formalin

Delayed fixation causes cell autolysis and nuclear fragmentation, severely compromising morphological evaluation

Fixation duration

Room temperature for 4–24 hours​ (depending on core size)

Under-fixation → tissue disintegration during decalcification; over-fixation → antigen masking, impairing immunohistochemistry

Fixative volume

Fixative volume should be 10–20 times​ the tissue volume

Ensures complete penetration

(3) Decalcification and Embedding

The most unique and challenging pre-processing step for bone marrow biopsy is decalcification:

Principle: Bone tissue contains abundant hydroxyapatite crystals, which must be dissolved by acidic decalcifying agents (e.g., EDTA, formic acid-formaldehyde mixtures) to soften the tissue to a sliceable state.

Method selection:

EDTA decalcification​ (recommended): Chelating action is gentle, preserves tissue antigens and DNA well, suitable for downstream IHC and molecular testing; disadvantage is prolonged duration (3–7 days).

Acid rapid decalcification​ (e.g., nitric acid method): Fast (several hours) but causes significant damage to antigens and nucleic acids, potentially affecting downstream assays.

Paraffin embedding: After decalcification, the tissue undergoes gradient alcohol dehydration, xylene clearing, paraffin infiltration, and embedding into a paraffin block.

(4) Sectioning and Staining

Stain Type

Specific Methods

Diagnostic Use

Routine stains

HE stain, Giemsa stain

Assess cellular density, fat proportion, abnormal cell infiltration patterns

Fibrosis evaluation

Gomori silver stain (reticulin), Masson's trichrome

Bone marrow fibrosis grading (MF-0 to MF-3)

Immunohistochemistry (IHC)

CD34, CD117, MPO, CD3, CD20, CD138, etc.

Determine abnormal cell lineage, assess minimal residual disease

Special stains

Congo red (amyloidosis), PAS (fungi/mucin)

Confirm specific pathological conditions


IV. In-Depth Comparison of Diagnostic Advantages

4.1 Unique Advantages of Bone Marrow Aspiration - Deep Analysis

(1) Single-Cell Resolution Morphological Diagnosis

The greatest strength of marrow smears is that each cell is "spread apart"​ - with good spreading technique, cells are arranged in a single monolayer without overlap. This enables the pathologist to examine every cell under oil immersion (1000×) for:

Nuclear chromatin coarseness and distribution patterns

Number, size, and prominence of nucleoli

Cytoplasmic color, granule types (azurophilic, neutrophilic, eosinophilic, etc.)

Cell size and morphological regularity

This "cell-level" resolution​ is unattainable with biopsy sections - in 3–5 μm thick tissue sections, nuclei frequently overlap vertically, cytoplasmic details are compressed, and precise classification of individual cells is extremely difficult.

(2) Detailed Megakaryocyte Assessment

Megakaryocytes are the largest cells in the marrow (up to 50–100 μm in diameter). Morphological abnormalities are diagnostically crucial for several disorders:

Abnormality

Morphological Features

Associated Disease

Giant forms

Cell body >100 μm, excessive lobulation (>10 lobes)

Megaloblastic anemia (B12/folate deficiency)

Megaloblastoid change

Enlarged cell body but limited lobulation; nuclear maturation lags behind cytoplasm

MDS, megaloblastic anemia

Micromegakaryocytes

Small cell body (comparable to lymphocytes), unlobated or minimally lobulated nucleus

MDS (especially 5q- syndrome), AML with recurrent genetic abnormalities

On smears, these abnormalities are readily apparent; in biopsy sections, megakaryocytes are often obscured by other cells and their full morphology is difficult to appreciate due to section thickness limitations.

(3) Quantifiable Value of Cytochemical Stains

Cytochemical staining results on marrow smears can be precisely quantified​ - for example, POX positivity rate is expressed as a percentage (e.g., "blast POX positivity 85%"), which is a core criterion for distinguishing AML from ALL. In biopsy sections, enzyme activity and chromogen deposition are affected by fixation and decalcification, yielding only semi-quantitative results ("weakly positive" or "focally positive"), without precise numerical values.

4.2 Unique Advantages of Bone Marrow Biopsy - Deep Analysis

(1) Spatial Proportion of Hematopoietic vs. Fatty Tissue

In biopsy sections, the ratio of red marrow (hematopoietic area) to yellow marrow (fatty area) can be directly visualized and quantified. Normal adult marrow contains approximately 30%–50% hematopoietic tissue and 50%–70% fat. Alterations in this ratio carry significant diagnostic implications:

Pathological State

Red/Yellow Marrow Ratio Change

Clinical Significance

Aplastic anemia

Red marrow drastically reduced (<10%), nearly entirely replaced by fat

Core criterion for confirming aplastic anemia

Myelodysplastic syndrome

Red marrow increased (50%–80%), with abnormal localization (ALIP phenomenon)

Supports MDS diagnosis

Myelofibrosis

Red marrow replaced by dense fibrous tissue

Required for PMF diagnosis

Leukemic infiltration

Red marrow almost completely occupied by a monomorphic population of leukemic cells

Assesses tumor burden

(2) Precise Evaluation of Nucleated Cell Density

Biopsy sections allow calculation of nucleated cell count per square millimeter​ or use of a semi-quantitative cellularity grading system​ (5-tier):

Cellularity Grade

Nucleated Cell Proportion

Corresponding Pathological State

Extremely hypercellular

>90%

CML blast phase, some AML

Markedly hypercellular

70%–90%

CML chronic phase, PV, ET

Cellular (normal)

30%–70%

Normal or mildly abnormal

Hypocellular

10%–30%

Some MDS, post-treatment states

Severely hypocellular

<10%

Severe aplastic anemia

This biopsy-based cellularity assessment is more objective than smear evaluation - smears only reflect cell density in "the tiny fraction that was aspirated," whereas biopsy reveals the "full panorama" of the entire marrow cavity.

(3) Avoidance of Sinusoidal Dilution - Truly Reflecting Hematopoietic Status

During aspiration, negative pressure inevitably draws sinusoidal blood along with marrow fluid, causing some degree of dilution. Although experienced operators can minimize this by controlling aspiration volume, it cannot be completely eliminated. Biopsy tissue cores, by contrast, are not subject to sinusoidal dilution - sinusoidal blood is washed away during fixation, and the cells seen on the section are exclusively parenchymal marrow cells. This is especially important in evaluating hypocellular MDS​ or early myelofibrosis.

(4) Diagnostic Value for Specific Diseases

Disease

Diagnostic Role of Biopsy

Mechanistic Explanation

Primary Myelofibrosis (PMF)

Gold standard for diagnosis

Smears cannot show fibrosis degree; reticulin staining on biopsy confirms MF grading

Hairy Cell Leukemia (HCL)

Characteristic diagnosis

Biopsy reveals "fried-egg" hairy cell infiltrates and prominent reticulin fibrosis; smears may miss HCL cells

MDS to AML progression

Early warning

Biopsy can demonstrate emergence and expansion of abnormal localization of immature precursors (ALIP), preceding abundant blasts on smears

Lymphoma marrow involvement

Infiltration pattern determination

Distinguishes nodular, interstitial, mixed, and diffuse patterns - critical for staging and treatment decisions

Metastatic tumors

Diagnostic confirmation

Clearly shows epithelial tumor nests or metastatic melanoma; IHC identifies primary site

(5) Differential Diagnosis of "Dry Tap" - The Irreplaceable Role of Biopsy

A "dry tap" is defined as: the aspiration needle has clearly entered the marrow cavity, but repeated attempts yield no fluid. Common causes and the diagnostic value of biopsy:

Cause of Dry Tap

Biopsy Findings

Diagnostic Significance

Myelofibrosis

Abundant reticulin fibers; marrow cavity filled with collagen

Confirms PMF or secondary myelofibrosis

Extensive malignant infiltration

Marrow cavity packed with metastatic carcinoma or melanoma cells, crowding out normal hematopoiesis

Identifies metastasis source (requires IHC)

Extreme leukemic hypercellularity

Marrow cavity almost entirely filled with dense leukemic cells; extremely high viscosity

Confirms AML/ALL (combined with any微量 smear obtained)

Marrow necrosis

Amorphous eosinophilic material and nuclear debris throughout the tissue

Suggests severe infection, DIC, or tumor lysis

Technical factors

Histologically normal hematopoiesis

Excludes pathological causes; repeat aspiration at a different site


V. Limitations Compared - Deep Analysis

5.1 Limitations of Bone Marrow Aspiration

(1) Destruction of Natural Architecture - Loss of the "Cellular Social Network"

Aspiration disperses bone marrow tissue into a single-cell suspension. While this facilitates individual cell examination, it means complete loss of spatial relationship information between cells, including:

Inability to determine whether blasts are clustered (ALIP phenomenon)

Inability to assess reticulin fiber proliferation

Inability to distinguish boundaries between hematopoietic and fatty zones

This information is precisely what is most critical in diagnosing MDS and myelofibrosis.

(2) Sinusoidal Dilution - The Risk of "Watering Down"

Even in the most experienced hands, aspirate specimens inevitably contain some proportion of sinusoidal blood. Studies indicate that approximately 10%–30% of cells in routine marrow aspirate smears originate from sinusoidal dilution. This dilution effect is particularly pronounced in:

Over-aspiration (>1 ml)

Overly rapid aspiration

Patients with significant hypersplenism (accelerated sinusoidal flow)

Intrinsically hypocellular marrow (fewer normal cells, higher dilution ratio)

The consequence: blast percentages are underestimated, potentially misclassifying high-risk MDS as low-risk, or missing an AML diagnosis entirely.

(3) Dry Tap - The "Dead End" of Examination Failure

As described above, when a dry tap occurs, aspiration yields no valid specimen. Without a subsequent biopsy, the patient faces a prolonged diagnostic gap and potentially the additional pain of repeat procedures.

5.2 Limitations of Bone Marrow Biopsy

(1) Difficulty in Cell Type Identification - "Facial Blindness in a Crowd"

In 3–5 μm thick tissue sections, nuclei overlap vertically and cytoplasm is compressed, leading to:

Difficulty distinguishing myeloblasts from monoblasts (POX staining on smears resolves this)

Occasional inability to differentiate erythroid precursors from lymphocytes

Extreme difficulty in identifying micromegakaryocytes

Thus, while biopsy can tell you "there are many densely packed cells here," it cannot precisely tell you what those cells actually are.

(2) Limited Visualization of Fine Intracellular Structures - "Insufficient Pixel Resolution"

Processing steps - fixation (formalin), decalcification (acidic environment), and embedding (heated paraffin) - cause some degree of cell shrinkage and distortion:

Nucleoli may become indistinct or disappear

Cytoplasmic granules may dissolve or shift position

Auer rods (characteristic of AML) are extremely difficult to identify in sections

On smears, these fine structures are clearly visible in freshly fixed or near-living cells.

(3) Difficulty Quantifying Cytochemical Stains - "Qualitative but Not Quantitative"

As noted, enzyme activity and antigen preservation in biopsy sections are affected by processing. Cytochemical staining results are mostly semi-quantitative (e.g., "positive" or "weakly positive"), lacking the precise percentage values achievable on smears. This is a clear shortcoming in the precise subtyping of acute leukemias.


VI. Complementary Relationship in Clinical Decision-Making - From Guidelines to Practice

6.1 Recommendations from Major Guidelines

Guideline Source

Recommendation

WHO Classification of Haematolymphoid Tumours (2016/2022)

For MDS, MPN, AML, etc., simultaneous aspiration and biopsy​ are recommended; combined use increases diagnostic accuracy by 15%–25%

NCCN MDS Guidelines

Bone marrow biopsy is mandatory for initial MDS diagnosis to assess blast percentage, fibrosis degree, and ALIP

Chinese Expert Consensus on Aplastic Anemia

Biopsy is essential for aplastic anemia diagnosis; smears alone cannot substitute

ELN AML Guidelines

Aspirate smears are central to AML diagnosis and classification; biopsy serves as a supplement (especially for fibrosis, angiogenesis, and MRD assessment)

6.2 Standardized "One Puncture, One Biopsy" Strategy

Major international hematology centers widely adopt the strategy of single anesthesia, single puncture site (posterior superior iliac spine), sequential aspiration followed by biopsy:

Step

Order

Rationale

Step 1

Perform aspiration first

Performing biopsy first may cause local bleeding and fibrosis, reducing subsequent aspiration success

Step 2

Perform biopsy second

Changes from aspiration have minimal impact on biopsy (which evaluates tissue architecture; minor bleeding does not affect overall assessment)

Step 3

Same puncture site

Reduces patient discomfort; both specimens come from the same anatomical location, directly comparable

6.3 Disease-Specific Selection Strategy

Clinical Scenario

Primary Test

Secondary/Adjunct

Rationale

Newly diagnosed acute leukemia

Aspiration smear

Biopsy (optional)

Smear sufficient for FAB classification and immunophenotyping; biopsy for fibrosis/angiogenesis

Suspected myelofibrosis

Biopsy

Smear (adjunct)

Biopsy is the only definitive diagnostic modality

Suspected MDS

Both simultaneously

-

WHO criteria require both

Aplastic anemia

Biopsy

Smear (adjunct)

Fat replacement assessment is key to diagnosis

Lymphoma staging

Biopsy

Smear (adjunct)

Biopsy shows infiltration pattern; smear may miss focal involvement

Multiple myeloma

Both simultaneously

-

Smear for plasma cell morphology; biopsy for plasma cell clustering and fibrosis

Metastatic cancer workup

Biopsy

Smear (adjunct)

IHC on biopsy identifies primary site; smear only occasionally reveals tumor cells

6.4 Insight from a Typical Case

Case: Male, 68 years old, progressive fatigue and splenomegaly. CBC: Hb 82 g/L, WBC 4.2×10⁹/L, PLT 58×10⁹/L. Peripheral smear shows occasional teardrop cells.

Aspiration alone: Might yield a slightly diluted specimen showing "hypocellularity with few abnormal cells" - insufficient for definitive diagnosis; could be misdiagnosed as "hypocellular MDS."

Biopsy alone: Would show marked fibrosis and clustered blasts, suggesting PMF, but precise blast classification would be impossible.

Combined: Smear shows left-shifted granulopoiesis with immature myeloid cells; biopsy shows MF-2 fibrosis, positive ALIP, and abnormal megakaryocyte morphology - comprehensive diagnosis: primary myelofibrosis (prefibrotic/early stage) with MDS features, providing a precise basis for subsequent treatment.

news-1-1